Compare
Edwards Lifesciences Corp vs Steris PLC vs Zimmer Biomet Holdings, Inc. vs Align Technology Inc
| Latest fiscal year | Edwards Lifesciences Corp EW | Steris PLC STE | Zimmer Biomet Holdings, Inc. ZBH | Align Technology Inc ALGN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-03-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $6.07B | $5.94B | $8.23B | $4.03B |
| Revenue growth (YoY) | +11.5% | +8.7% | +7.2% | +0.9% |
| Gross margin | 78.0% | 44.2% | n/a | 67.2% |
| Operating margin | 20.8% | 18.6% | 13.3% | 13.5% |
| Net margin | 17.6% | 13.2% | 8.6% | 10.2% |
| Net income | $1.07B | $782.30M | $705.10M | $410.35M |
| EPS (Diluted) | $1.83 | $7.93 | $3.55 | $5.65 |
| Operating cash flow | $1.60B | $1.34B | $1.70B | $593.22M |
| Free cash flow | $1.33B | $972.40M | $1.47B | $490.78M |
| Cash & equivalents | $2.94B | n/a | $591.90M | $1.09B |
| Total assets | $13.70B | $10.74B | $23.09B | $6.23B |
| Total liabilities | $3.36B | $3.54B | $10.39B | $2.18B |
| Shareholders' equity | $10.34B | $7.20B | $12.71B | $4.05B |
| Return on year-end equity | 10.3% | 10.9% | 5.5% | 10.1% |
| Shares outstanding | 580.70M | 97.80M | n/a | 71.36M |
Revenue, most recent five fiscal years
| Fiscal year | Edwards Lifesciences Corp | Steris PLC | Zimmer Biomet Holdings, Inc. | Align Technology Inc |
|---|---|---|---|---|
| Latest | $6.07B Ended 2025-12-31 | $5.94B Ended 2026-03-31 | $8.23B Ended 2025-12-31 | $4.03B Ended 2025-12-31 |
| 1 year earlier | $5.44B Ended 2024-12-31 | $5.46B Ended 2025-03-31 | $7.68B Ended 2024-12-31 | $4.00B Ended 2024-12-31 |
| 2 years earlier | $5.01B Ended 2023-12-31 | $5.14B Ended 2024-03-31 | $7.39B Ended 2023-12-31 | $3.86B Ended 2023-12-31 |
| 3 years earlier | $4.46B Ended 2022-12-31 | $4.54B Ended 2023-03-31 | $6.94B Ended 2022-12-31 | $3.73B Ended 2022-12-31 |
| 4 years earlier | $5.23B Ended 2021-12-31 | $4.22B Ended 2022-03-31 | $6.83B Ended 2021-12-31 | $3.95B Ended 2021-12-31 |